<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="EUR" hierarchy="1" humanitarian="1" iati-activities:version="2.02" xml:lang="EN" xmlns:budgetline="http://diplomatie.be/oda/currentbudget.xlsx" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-2-10-2073</iati-identifier>
  <reporting-org ref="XM-DAC-2-10" type="10">
   <narrative xml:lang="FR">Direction-G&#xE9;n&#xE9;rale Coop&#xE9;ration au D&#xE9;veloppement et Aide humanitaire</narrative>
   <narrative xml:lang="EN">Directorate-general Development Cooperation and Humanitarian Aid</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">ESPEN - Expanded Special Project for Elimination of Neglected Tropical Diseases - PG/2019/01</narrative>
   <narrative xml:lang="FR">ESPEN - Large projet sp&#xE9;cial pour l&apos;&#xE9;limination des maladies tropicales n&#xE9;glig&#xE9;es</narrative>
  </title>
  <description type="3">
   <narrative xml:lang="EN">ESPEN&#x2019;s remit covers 47 countries in Africa and five countries in the WHO Regional Eastern Mediterranean Office (EMRO): Sudan, Egypt, Somalia, Djibouti and Yemen.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Intermediate Outcome 1: Scale up treatments to reach 100% geographical coverage

Intermediate Outcome 2: Scale-down and stop treatments once elimination target has been achieved 

Intermediate Outcome 3: Strengthen access and quality of information to enable evidence-based action

Intermediate Outcome 4: Improve the efficient and effective use of donated medicines


 ESPEN&#x2019;s primary goal is to significantly reduce the prevalence of five NTDs between 2016 and 2020, in concert with the WHO&#x2019;s Roadmap for NTDs An investment of $5 million USD between 2018 and 2020, as an example, would leverage over $130 million in donated drugs to support health system strengthening and expand universal health coverage for NTDs to over 11.5 million people annually. There is an opportunity to make this go even further by channeling it through ESPEN, where it would be matched 1:1 by the Bill and Melinda Gates Foundation meaning the investment and reach would be doubled, while helping ESPEN build upon its current progress with the four following objectives:
&#x2022;	Scaling up treatments towards the achievement of 100% geographical coverage
&#x2022;	Scaling down: stopping treatments once transmission has been interrupted or control achieved
&#x2022;	Strengthening information systems for evidence-based action
&#x2022;	Improving the effective use of donated medicines through enhanced supply chain management</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">This grant will be used to support the ESPEN in its next two years of operation to execute against its primary goal and accelerate the reduction of burden of the 5 PC-NTDs.
The Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) was established in the spirit of partnership between WHO Regional Office for Africa (AFRO), Member States and NTD partners in an effort to mobilize political, technical and financial resources to reduce the burden of the five most prevalent Neglected Tropical Diseases (NTDs) in Africa amenable to preventive chemotherapy (PC) through Mass Drug Administration (MDA): lymphatic filariasis (LF), onchocerciasis (oncho), soil-transmitted helminths (STH), schistosomiasis (SCH) and trachoma (TRA). Bound by the principles of transparency and accountability, ESPEN is positioned to serve as a coordinating entity among partners and stakeholders and add value to partner investments through technical and operational support to endemic countries for the control and elimination of these disfiguring and debilitating diseases.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Direction-G&#xE9;n&#xE9;rale Coop&#xE9;ration au D&#xE9;veloppement et Aide humanitaire</narrative>
   <narrative xml:lang="EN">Directorate-general Development Cooperation and Humanitarian Aid</narrative>
  </participating-org>
  <participating-org role="4" type="40">
   <narrative xml:lang="FR">NU OMS/WHO - Organisation mondiale de la sant&#xE9; - PRT</narrative>
   <narrative xml:lang="EN">UN World Health Organisation - voluntary funds WHO_OMS - WHO - PRT</narrative>
  </participating-org>
  <other-identifier ref="2073" type="A1">
   <owner-org ref="XM-DAC-2-10">
    <narrative xml:lang="EN">Directorate-general Development Cooperation and Humanitarian Aid</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier type="A2"></other-identifier>
  <activity-status code="4"></activity-status>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Direction-G&#xE9;n&#xE9;rale Coop&#xE9;ration au D&#xE9;veloppement et Aide humanitaire</narrative>
    <narrative xml:lang="EN">Directorate-general Development Cooperation and Humanitarian Aid</narrative>
   </organisation>
   <email>Info.DGD@diplobel.fed.be</email>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-region code="289" percentage="100" vocabulary="1"></recipient-region>
  <sector code="72050" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="B03" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <document-link format="APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.WORDPROCESSINGML.DOCUMENT" url="http://www.diplomatie.be/oda/31222_PROGDESCR_2._ESPEN_-_Proposal_Belgium_-_08.11.2018.docx">
   <title>
    <narrative xml:lang="EN">2._ESPEN_-_Proposal_Belgium_-_08.11.2018.docx</narrative>
   </title>
   <category code="A01"></category>
   <category code="A02"></category>
   <category code="A03"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-02-20"></document-date>
  </document-link>
  <document-link format="APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.SPREADSHEETML.SHEET" url="http://www.diplomatie.be/oda/31223_PROGDESCR_2bis._ESPEN_-_Proposal_Belgium_-_Budget_-_08.11.2018.xlsx">
   <title>
    <narrative xml:lang="EN">2bis._ESPEN_-_Proposal_Belgium_-_Budget_-_08.11.2018.xlsx</narrative>
   </title>
   <category code="A01"></category>
   <category code="A02"></category>
   <category code="A03"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-02-20"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://www.diplomatie.be/oda/31227_LEGAL_AGREEMENT_6._FA_WHO-Belgium_23_Sept_2016.pdf">
   <title>
    <narrative xml:lang="EN">6._FA_WHO-Belgium_23_Sept_2016.pdf</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-02-20"></document-date>
  </document-link>
  <conditions attached="0"></conditions>
  <budgetline:code>5451356026</budgetline:code>
  <budgetline:descr>54 51 356026 Humanitarian programs</budgetline:descr>
 </iati-activity>
</iati-activities>
